Ian MacLachlan
- Molecular Biology top 1%
- Cancer Research top 1%
- Genetics top 2%
- Immunology top 2%
- Infectious Diseases top 2%
- Co-authors
- Adam D. JudgeKevin McClintockMarjorie RobbinsLorne PalmerVandana SoodJames HeyesDianne FangAmy C. H. Lee
- Topics
- RNA Interference and Gene Delivery (31 papers)Advanced biosensing and bioanalysis techniques (12 papers)Virus-based gene therapy research (10 papers)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Ian MacLachlan
49 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 5.5k
- Cancer Research 1.4k
- Genetics 1.1k
- Immunology 1.1k
- Infectious Diseases 776
Countries citing papers authored by Ian MacLachlan
This map shows the geographic impact of Ian MacLachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian MacLachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian MacLachlan more than expected).
Fields of papers citing papers by Ian MacLachlan
This network shows the impact of papers produced by Ian MacLachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian MacLachlan. The network helps show where Ian MacLachlan may publish in the future.
Co-authorship network of co-authors of Ian MacLachlan
This figure shows the co-authorship network connecting the top 25 collaborators of Ian MacLachlan. A scholar is included among the top collaborators of Ian MacLachlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian MacLachlan. Ian MacLachlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 63 | |
| 2 | 190 | |
| 3 | 77 | |
| 4 | 44 | |
| 5 | 21 | |
| 6 | 14 | |
| 7 | 64 | |
| 8 | 60 | |
| 9 | 342 | |
| 10 | 273 | |
| 11 | 181 | |
| 12 | 171 | |
| 13 | 225 | |
| 14 | 437 | |
| 15 | Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsbreakdown → | 908 |
| 16 | 257 | |
| 17 | 20 | |
| 18 | 34 | |
| 19 | 56 | |
| 20 | 207 |
About Ian MacLachlan
Ian MacLachlan is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 49 papers that have together received 6.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (31 papers), Advanced biosensing and bioanalysis techniques (12 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (5.5k citations) and Immunology (1.1k citations). Ian MacLachlan has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Adam D. Judge, Kevin McClintock, Marjorie Robbins, Lorne Palmer, Vandana Sood, James Heyes, Dianne Fang, Amy C. H. Lee, Ellen Ambegia and K. Helen Bremner. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.